Communiqués Surgical Science Sweden AB

Actions

Marché Fermé - Nasdaq Stockholm Autres places de cotation 18:00:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
125,1 ^SEK	-2,87%		-3,62%	-31,45%

15/05	Surgical Science Sweden AB (publ) annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
15/04	Gisli Hennermark quitte son poste de PDG de Surgical Science Sweden AB (publ)	CI

Report from the Annual General Meeting of Surgical Science Sweden AB (publ)	16/05	AQ
Interim report January – March 2024: PROPRIETARY SIMULATORS WEAK, INDUSTRIAL SEGMENT STRONG	15/05	AQ
Conference call regarding interim report Q1	02/05	AQ
Notice of annual general meeting in SURGICAL SCIENCE SWEDEN AB (publ)	15/04	AQ
Gisli Hennermark to be nominated to Surgical Science's board	12/04	AQ
CEO Gisli Hennermark will leave Surgical Science in March 2025	12/03	AQ
Surgical Science Sweden Q4 2023 - Long-term high quality, short-term black box	22/02	AQ
Year-end report 2023: STRONG LICENSE REVENUE, WEAKER SIMULATOR SALES	21/02	AQ
Conference call regarding Year-end Report 2023	12/02	AQ
Exercise of options against Surgical Science's two largest shareholders	15/01	AQ
Surgical Science changes Certified Adviser to Carnegie Investment Bank AB (publ)	30/11	AQ
Interim report January – September 2023: STRONG MARGINS DESPITE WEAKER GROWTH	09/11	AQ
Conference call regarding Interim Report Q3	25/10/23	AQ
Nomination Committee of Surgical Science Sweden AB (publ)	24/10/23	AQ
The situation in Israel	09/10/23	AQ
Interim report January – June 2023: LICENSE REVENUE CONTINUED TO INCREASE, VERY STRONG CASH FLOW	24/08/23	AQ
EXERCISE OF OPTIONS PROGRAM 2020/23	02/06/23	AQ
Report from the Annual General Meeting of Surgical Science Sweden AB (publ)	17/05/23	AQ
Interim report January – March 2023: 2023 STARTED VERY STRONGLY	16/05/23	AQ
Annual Report 2022	18/04/23	AQ

Aucun résultat pour cette recherche